Apply now for the 2021 Noster and Science Microbiome Prize
The NOSTER Science Microbiome Prize is an international prize that rewards innovative research by investigators, under the age of 35, who are working on the functional attributes of the microbiota. The research can include any organism that has potential to contribute to our understanding of human or veterinary health and disease, or to guide therapeutic interven-tions. The winner and finalists will be chosen by a committee of independent scientists, chaired by a senior editor at Science. The top prize includes a complimentary membership to AAAS, an online subscription to Science, and $25,000 (USD).
Apply by 1/24/21 at www.sciencemag.org/noster
Prize Details
· About
· Winners
Questions/Inquiries:
2020 Noster Prize Winner
GRAND PRIZE WINNER
Oliver Harrison
Oliver Harrison received an undergraduate degree from the University of Bath and a Ph.D. from the University of Oxford. After completing his postdoctoral fellowship at the National Institutes of Health, Oliver started his laboratory in the Center for Fundamental Immunology at Benaroya Research Institute in 2019. His research investigates how T and B cell responses to commensal microbes promote barrier tissue integrity and repair, and how this goes awry in disease. Read his prize-winning research here.
FINALIST
Mariana X. Byndloss
Mariana X. Byndloss received her D.V.M. and a Ph.D. from Universidade Federal de Minas Gerais in Brazil. After completing her postdoctoral fellowship at the University of California, Davis, Mariana started her laboratory in the Department of Pathology, Microbiology, and Immunology at Vanderbilt University Medical Center in 2018. Her research aims to understand how inflammation-mediated changes in gut epithelial metabolism lead to gut dysbiosis and increased risk of infectious gastroenteritis by Salmonella typhimurium and noncommunicable diseases, namely obesity-associated cardiovascular disease and colon cancer. Read her research here.
FINALIST
Chun-Jun (CJ) Guo
Chun-Jun (CJ) Guo received undergraduate degrees from Fudan University and a Ph.D. from the University of Southern California. After completing his postdoctoral fellowship at the University of California, San Francisco, and Stanford University in the Fischbach group, CJ started his laboratory in the Jill Roberts Institute for Research in Inflammatory Bowel Disease at Weill Cornell Medicine in 2018. His research uses CRISPR-based microbial genetics, state-of-the-art analytical chemistry, and healthy and diseased mouse models to mechanistically dissect how microbiome-derived genes, pathways, and metabolites affect host biology. Read his research here.
转载本文请联系原作者获取授权，同时请注明本文来自宁利中科学网博客。
链接地址：https://wap.sciencenet.cn/blog-750818-1264064.html?mobile=1
收藏
